(주)팍스젠바이오

분자진단 제품을 연구개발 및 제조하는 벤처기업, 분자진단과 면역진단을 결합한 '키메라' 같은 MPCR-ULFA Kit 개발

(주)팍스젠바이오

사이트맵

NEWS & EVENTS

News
HOME > NEWS & EVENTS > News
PaxGenBio Co., Ltd. to exhibit ‘MPCR-ULFA platform technology', a Multiple Rapid Molecular Diagnosis System
작성자
관리자
등록일
2021.02.16 10:31
조회수
1,398

PaxGenBio Co., Ltd. to exhibit ‘MPCR-ULFA platform technology', a Multiple Rapid Molecular Diagnosis System


PaxGenBio Co., Ltd. (CEO Park Young-seok, www.paxgenbio.com) will participate in the 36th Korea International Medical Device & Hospital Equipment Show (KIMES 2021) held at COEX in Seoul for four days from March 18 (Thu) to 21 (Sun).


 



e8419ea72a5dacb4973be98361cd64a5_1613438983_6782.jpg
MPCR-ULFA Technology diagram 


 


Multiple rapid molecular diagnosis system' 'MPCR-ULFA (Multiplex PCR-Universal Lateral Flow Assay) platform technology' consists of multi-molecular diagnostic techniques that simultaneously amplify multiple genes and molecular rapid and accurate analysis of the results of multiple amplified genes. Multiple rapid molecular diagnosis technology is a gene-typing source technology with four patents registered, including U.S. patents, and is a quick and convenient molecular diagnosis kit that allows visual infection and genotype analysis.


 



e8419ea72a5dacb4973be98361cd64a5_1613439003_7909.jpg
PaxView® HPV 20 Genotyping MPCR-ULFA Kit 


 


Based on the MPCR-ULFA platform technology, PaxgenBio is infected with human papilloma virus (HPV), a microorganism that causes cervical cancer, in particular, whether it is infected by types 16 and 18, which are the typical causes of cancer. PaxView® HPV 16/18/Others MPCR-ULFA Kit, which allows you to visually check the analysis results, and PaxView® HPV 20 Genotyping MPCR-ULFA Kit, which can analyze the genotype of 20 types of HPV, and can diagnose tuberculosis. PaxView® TB/NTM MPCR-ULFA Kit, PaxView® CT/NG/TP MPCR-ULFA Kit for simultaneously diagnosing chlamydia, gonorrhea, syphilis, and other sexually transmitted diseases, PaxView® SARS-CoV-2 MPCR-ULFA Kit was developed to diagnose Covid-19 infections.


 



e8419ea72a5dacb4973be98361cd64a5_1613439020_9522.jpg
PaxView® SARS-CoV-2 MPCR-ULFA Kit 


 


Through the Korea International Cooperation Agency (KOICA) CTS project, Paxgenbio participated in the project to combat tuberculosis in Indonesia, the world's second highest prevalence rate of tuberculosis, and promoted overseas procurement markets such as the WHO, starting with the tuberculosis diagnosis kit and HPV diagnosis kit for high-risk groups in Asia. Through the discovery of major national agencies, entry into the South American market, and business development with global partners, we are promoting sales expansion to European and Chinese diagnostic testing centers for 20 HPV genotyping kits and major sexually transmitted diseases kits. the Corona 19 diagnostic kit is currently in discussions with the Philippine government for export.




e8419ea72a5dacb4973be98361cd64a5_1613439093_7726.jpg
PaxView®TB/NTM MPCR-ULFA Kit 

 

source: KIMES 2021